Stephens & Co. Maintains Equal-Weight on Exelixis, Raises Price Target to $29
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. has maintained an Equal-Weight rating on Exelixis (NASDAQ:EXEL) while raising the price target from $23 to $29.
October 30, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. has maintained an Equal-Weight rating on Exelixis and increased the price target from $23 to $29, indicating a positive outlook.
The increase in the price target from $23 to $29 by Stephens & Co. suggests a positive outlook for Exelixis, which could lead to a short-term increase in stock price. The maintenance of an Equal-Weight rating indicates a balanced view, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100